On October 13, 2023, the Supervisory Board of Directors (the “Board”) of the Company temporarily appointed Ms. Anne Johnson, the Company’s Chief Accounting Officer (principal accounting officer), to act as the Company’s Interim Chief Financial Officer (principal financial officer) while Mr. Stephen Bardin is on parental leave.
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 1.0
Anne Johnson was appointed as Interim Chief Financial Officer at ATAI Life Sciences N.V..
Action
appointed
Role
Interim Chief Financial Officer
Exact text from the filing
On October 13, 2023, the Supervisory Board of Directors (the “Board”) of the Company temporarily appointed Ms. Anne Johnson, the Company’s Chief Accounting Officer (principal accounting officer), to act as the Company’s Interim Chief Financial Officer (principal financial officer) while Mr. Stephen Bardin is on parental leave.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.